Stock Report

Download full stock data and analysis for free Last Updated: 02-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Arvind Remedies Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ARVINDREM | BSE: 531823

₹4.70

up-down-arrow ₹-0.24 (-4.86%)

As on 13-Jun-2016IST

Market cap

info icon

₹32 Cr

Revenue (TTM)

info icon

₹12 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -40.87 -88.03 -97.68 -74.14 -49.88
EBIT 93.85 21.05 7.26 -196.75 -222.55
Net Profit 73.74 -517.04 61.08 -241.86 -248.18
EPS 73.74 -517.08 61.08 -- -232.42
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMJun-15Jun-14
EBIT-Margin info -----980.72-9.23--
Net Margin info -----1,121.27-40.36--
Return on equity info -------287.76--
Return on Capital info -------31.88--
Return on Assets info -----49.14-34.13--
Debt to Equity (x) info ----0.00-15.10--

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
-31.88
20.42
20.22
16.18
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
-287.76
26.60
26.51
15.09
Peer Median
10.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-49.14

Lower than Peers by 55.72

Profit after tax / Average Total assets * 100

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
-49.14
-34.13
6.09
5.62
3.99
Peer Median
6.58
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-980.72

Lower than Peers by 993.31

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
-980.72
-9.23
17.89
18.24
14.78
Peer Median
12.59
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-1,121.27

Lower than Peers by 1,130.04

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
-1,121.27
-40.36
6.46
6.11
4.44
Peer Median
8.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
0.00
-36.92
7.53
7.55
4.97
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-97.68

Lower than Peers by 105.61

Year on year growth in net sales

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
-97.68
-13.61
37.16
52.13
20.43
Peer Median
7.93
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

7.26

Lower than Peers by 9.26

Year on year growth in operating profit (EBIT)

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
7.26
--
34.58
87.68
66.28
Peer Median
16.52
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

61.08

Higher than Peers by 43.83

Year on year growth in profit after tax

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
61.08
-643.37
45.01
109.26
14.83
Peer Median
17.25
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

61.08

Higher than Peers by 50.76

Year on year growth in earnings per share

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
61.08
-643.38
2.66
109.28
14.82
Peer Median
10.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
-118.25
59.38
25.80
11.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
-15.10
2.29
3.05
2.67
Peer Median
0.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-2.36

--

(Short term borrowings / Net worth)

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
-2.36
-11.10
1.18
1.12
1.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.44

Lower than Peers by 1.30

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
0.44
0.84
1.27
1.32
1.23
Peer Median
1.74
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.44

Lower than Peers by 0.74

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
0.44
0.83
0.90
0.95
0.87
Peer Median
1.18
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
-3.58
2.12
2.06
2.34
Peer Median
7.76
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

2,330.59

Higher than Peers by 2,304.84

Debtors outstanding / Net Sales * 100

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
2,330.59
60.67
36.54
36.36
38.91
Peer Median
25.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.04

Lower than Peers by 0.62

Sales / Average Total Assets

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
0.04
0.84
1.00
0.98
0.94
Peer Median
0.66
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
187.91
108.41
106.58
121.83
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
46.79
59.56
54.10
57.96
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
23.76
43.98
34.38
38.73
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
210.94
123.98
126.31
141.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
--
4.99
3.66
56.66
Peer Median
42.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

-0.20

Lower than Peers by 4.46

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
-0.20
-1.70
1.08
0.87
0.81
Peer Median
4.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
--
--
1.85
3.25
3.07
Peer Median
0.11
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-8.56

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
-8.56
-22.28
5.14
4.80
6.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

32

Lower than Peers by 7,816

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Jun-15
Mar-14
Mar-13
Mar-12
Arvind Remedies
32
85
294
149
110
Peer Median
7,848
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...